D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 80 Citations 20,478 374 World Ranking 12011 National Ranking 6270

Research.com Recognitions

Awards & Achievements

Fellow of The National Academy of Public Administration

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

The scientist’s investigation covers issues in Cancer research, Ovarian cancer, Pathology, Molecular biology and Gene expression. His Cancer research research incorporates elements of Carcinogenesis, Cancer, microRNA and Immunology. His Ovarian cancer study is concerned with the larger field of Internal medicine.

His Pathology study combines topics from a wide range of disciplines, such as Ovarian tumor, Antibody and Ovary. The study incorporates disciplines such as Stratified squamous epithelium, Genetics, Ovarian carcinoma, Vimentin and Differential display in addition to Molecular biology. The various areas that Samuel C. Mok examines in his Gene expression study include Tumor suppressor gene, Endometrium, XIST and Chromatin.

His most cited work include:

  • Dicer, Drosha, and outcomes in patients with ovarian cancer (585 citations)
  • Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. (462 citations)
  • Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer (422 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Ovarian cancer, Cancer research, Cancer, Pathology and Internal medicine. Specifically, his work in Ovarian cancer is concerned with the study of Ovarian carcinoma. His research in Cancer research intersects with topics in Immunohistochemistry, Immunology, Cell growth, Ovarian tumor and Metastasis.

His Cancer study incorporates themes from Molecular biology, Immune system and Bioinformatics. Samuel C. Mok combines subjects such as Adenocarcinoma, Loss of heterozygosity and Ovary with his study of Pathology. His Internal medicine research includes themes of Endocrinology, Gene expression and Oncology.

He most often published in these fields:

  • Ovarian cancer (55.72%)
  • Cancer research (50.00%)
  • Cancer (28.61%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (50.00%)
  • Ovarian cancer (55.72%)
  • Cancer (28.61%)

In recent papers he was focusing on the following fields of study:

Samuel C. Mok mostly deals with Cancer research, Ovarian cancer, Cancer, Tumor microenvironment and Stromal cell. His research integrates issues of Cell growth, Immune system, Ovarian tumor, Gene silencing and MAPK/ERK pathway in his study of Cancer research. His Immune system study combines topics in areas such as Cytotoxic T cell, Pathology and Mass cytometry.

His Ovarian cancer research is within the category of Internal medicine. His studies in Cancer integrate themes in fields like Proteome, Proteomics, Serous fluid and Clinical trial. His study in Stromal cell is interdisciplinary in nature, drawing from both Cancer cell, Stroma, Immunology and Carcinogenesis.

Between 2015 and 2021, his most popular works were:

  • Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. (332 citations)
  • CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks (204 citations)
  • Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance (49 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

The scientist’s investigation covers issues in Ovarian cancer, Cancer research, Cancer cell, Cancer and Tumor microenvironment. Samuel C. Mok studies Ovarian cancer, namely Ovarian tumor. His Cancer research research incorporates elements of Cell growth, Interferon, Paclitaxel, Gene silencing and MAPK/ERK pathway.

His Cell growth research integrates issues from Serous fluid, MMP1, Ovary, Carcinoma and Endometrial cancer. His Cancer cell study also includes

  • Stromal cell which connect with Stroma,
  • Computational biology together with Gene regulatory network, Regulation of gene expression, Basal and Cell culture. His work focuses on many connections between Cancer and other disciplines, such as Immune system, that overlap with his field of interest in Microsatellite instability and Cell type.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dicer, Drosha, and outcomes in patients with ovarian cancer

William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat.
The New England Journal of Medicine (2008)

831 Citations

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Ronny Drapkin;Hans Henning von Horsten;Yafang Lin;Samuel C. Mok.
Cancer Research (2005)

823 Citations

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

Toshiyasu Taniguchi;Marc Tischkowitz;Najim Ameziane;Shirley V. Hodgson.
Nature Medicine (2003)

688 Citations

Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer

Jae Hoon Kim;Steven J. Skates;Toshimitsu Uede;Kwong Kwok Wong.
JAMA (2002)

623 Citations

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.

Chi Lam Au Yeung;Ngai Na Co;Tetsushi Tsuruga;Tsz Lun Yeung.
Nature Communications (2016)

551 Citations

Potential markers that complement expression of CA125 in epithelial ovarian cancer

Daniel G. Rosen;Lin Wang;J. Neeley Atkinson;Yinhua Yu.
Gynecologic Oncology (2005)

500 Citations

Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract.

Alison J. Quayle;Edith Porter;Aimee A. Nussbaum;Yun Mei Wang.
American Journal of Pathology (1998)

428 Citations

Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry

Bin Ye;Daniel W. Cramer;Steven J. Skates;Steven P. Gygi.
Clinical Cancer Research (2003)

393 Citations

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

Tomas Bonome;Ji Young Lee;Dong Choon Park;Mike Radonovich.
Cancer Research (2005)

384 Citations

Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology

Samuel C. Mok;Julie Chao;Steven Skates;Kwong Kwok Wong.
Journal of the National Cancer Institute (2001)

376 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Samuel C. Mok

Eleftherios P. Diamandis

Eleftherios P. Diamandis

Mount Sinai Hospital

Publications: 185

Michael J. Birrer

Michael J. Birrer

University of Arkansas for Medical Sciences

Publications: 74

Anil K. Sood

Anil K. Sood

The University of Texas MD Anderson Cancer Center

Publications: 71

Robert C. Bast

Robert C. Bast

The University of Texas MD Anderson Cancer Center

Publications: 63

David M. Gershenson

David M. Gershenson

The University of Texas MD Anderson Cancer Center

Publications: 62

George M. Yousef

George M. Yousef

University of Toronto

Publications: 57

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 53

Ie Ming Shih

Ie Ming Shih

Johns Hopkins University

Publications: 51

Beth Y. Karlan

Beth Y. Karlan

University of California, Los Angeles

Publications: 48

Andreas Scorilas

Andreas Scorilas

National and Kapodistrian University of Athens

Publications: 47

Andrew Berchuck

Andrew Berchuck

Duke University

Publications: 45

Ben Davidson

Ben Davidson

Oslo University Hospital

Publications: 43

Karen H. Lu

Karen H. Lu

The University of Texas MD Anderson Cancer Center

Publications: 40

David G. Huntsman

David G. Huntsman

University of British Columbia

Publications: 38

David D.L. Bowtell

David D.L. Bowtell

Peter MacCallum Cancer Centre

Publications: 37

Robert J. Kurman

Robert J. Kurman

Johns Hopkins University

Publications: 36

Trending Scientists

Miroslaw Truszczynski

Miroslaw Truszczynski

University of Kentucky

Campbell D. Carter

Campbell D. Carter

United States Air Force Research Laboratory

James S. Hyde

James S. Hyde

Medical College of Wisconsin

Hiroshi Nishihara

Hiroshi Nishihara

Tokyo University of Science

Antonio Tiripicchio

Antonio Tiripicchio

University of Parma

Shoji Tajima

Shoji Tajima

Osaka University

Sven-Erik Jacobsen

Sven-Erik Jacobsen

University of Copenhagen

Andrew S. Brierley

Andrew S. Brierley

University of St Andrews

Martin E. Alexander

Martin E. Alexander

Wild Rose Fire Behaviour

George K. Kostopoulos

George K. Kostopoulos

University of Patras

David B. Lewis

David B. Lewis

Stanford University

S. Shirley Feldman

S. Shirley Feldman

Stanford University

Alfred F. Michael

Alfred F. Michael

University of Minnesota

Calvin J. Hobel

Calvin J. Hobel

Cedars-Sinai Medical Center

Benny Chung-ying Zee

Benny Chung-ying Zee

Chinese University of Hong Kong

Ted Chiricos

Ted Chiricos

Florida State University

Something went wrong. Please try again later.